TOPROL XL

This brand name is authorized in Australia, United States

Active ingredients

The drug TOPROL XL contains one active pharmaceutical ingredient (API):

1 Metoprolol UNII TH25PD4CCB - METOPROLOL SUCCINATE

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation. Read about Metoprolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TOPROL XL Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB02	Metoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8733P, 8734Q, 8735R
Country: US	FDA, National Drug Code	Identifier(s): 0186-1088, 0186-1090, 0186-1092, 0186-1094, 67544-282, 67544-491, 67544-555, 70347-025, 70347-050, 70347-100, 70347-200, 71610-035, 71610-038, 71610-373